These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9884192)

  • 1. Estimation of impurity profiles of drugs and related materials Part 18. Impurities and degradation products of mazipredone.
    Gazdag M; Babják M; Brlik J; Mahó S; Tuba Z; Görög S
    J Pharm Biomed Anal; 1998 Sep; 17(6-7):1029-36. PubMed ID: 9884192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of impurity profiles of drugs and related materials: part 19: theme with variations. Identification of impurities in 3-oxosteroids.
    Görög S; Babják M; Balogh G; Brlik J; Dravecz F; Gazdag M; Horváth P; Laukó A; Varga K
    J Pharm Biomed Anal; 1998 Dec; 18(4-5):511-25. PubMed ID: 9919951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a new stability indicating reversed phase liquid chromatographic method for the determination of prednisolone acetate and impurities in an ophthalmic suspension.
    Marley A; Stalcup AM; Connolly D
    J Pharm Biomed Anal; 2015 Jan; 102():261-6. PubMed ID: 25459922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estimation of impurity profiles of drugs and related materials. 20. Methodological problems in the identification and determination of organic impurities].
    Görög S
    Acta Pharm Hung; 2000; 70(3-6):131-7. PubMed ID: 11379019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Impurity Profiling Methods Using Modern Analytical Techniques.
    Ramachandra B
    Crit Rev Anal Chem; 2017 Jan; 47(1):24-36. PubMed ID: 27070830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC method for simultaneous analysis of ticagrelor and its organic impurities and identification of two major photodegradation products.
    Bueno LM; Manoel JW; Giordani CF; Mendez AS; Volpato NM; Schapoval EE; Steppe M; Garcia CV
    Eur J Pharm Sci; 2017 Jan; 97():22-29. PubMed ID: 27816632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a stability-indicating assay including the isolation and characterization of degradation products of metaxalone by LC-MS.
    Rao RN; Farah H; Sahu PK; Janarthan M; Naidu ChG
    Biomed Chromatogr; 2013 Dec; 27(12):1733-40. PubMed ID: 23881540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of impurity profiles in drugs and related materials. Part 11--The role of chromatographic and spectroscopic methods in the estimation of side-reactions in drug syntheses.
    Görög S; Balogh G; Csehi A; Csizér E; Gazdag M; Halmos Z; Hegedüs B; Herényi B; Horváth P; Laukó A
    J Pharm Biomed Anal; 1993; 11(11-12):1219-26. PubMed ID: 8123737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural elucidation of stress degradation products of ampicillin sodium by liquid chromatography/hybrid triple quadrupole linear ion trap mass spectrometry and liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry.
    Li T; Xu X; Fu S; Zhang J; Zhang K; Wang S; Zhao M; Ding W; Wang Q
    Rapid Commun Mass Spectrom; 2014 Sep; 28(17):1929-36. PubMed ID: 25088136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of steroids. XXXVIII. The use of high-performance liquid chromatography with diode-array UV detection for estimating impurity profiles of steroid drugs.
    Görög S; Herényi B
    J Chromatogr; 1987 Jul; 400():177-86. PubMed ID: 3667745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug impurity profiling strategies.
    Görög S; Babják M; Balogh G; Brlik J; Csehi A; Dravecz F; Gasdag M; Horváth P; Laukó A; Varga K
    Talanta; 1997 Sep; 44(9):1517-26. PubMed ID: 18966892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of process related impurities and degradation products of bicalutamide and development of RP-HPLC method for impurity profile study.
    Nageswara Rao R; Narasa Raju A; Narsimha R
    J Pharm Biomed Anal; 2008 Feb; 46(3):505-19. PubMed ID: 18162355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high pH based reversed-phase high performance liquid chromatographic method for the analysis of aminoglycoside plazomicin and its impurities.
    Tan L; Wlasichuk KB; Schmidt DE; Campbell RL; Hirtzer P; Cheng L; Karr DE
    J Pharm Biomed Anal; 2012 Jul; 66():75-84. PubMed ID: 22459505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of the impurity in auramine O by high performance liquid chromatography-ion trap-time of flight mass spectrometry and preparation of the auramine O reference standard by preparative high performance liquid chromatography].
    Che F; Lu Y; Xi X; Lan T; Wei Y
    Se Pu; 2019 Mar; 37(3):299-304. PubMed ID: 30900859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products, metabolites) in various matrices.
    Görög S; Bihari M; Csizér E; Dravetz F; Gazdag M; Herényi B
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):85-92. PubMed ID: 8833970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.